Integrated DNA Technologies, Inc. (IDT) develops, manufactures and markets nucleic acid products for the life sciences industry in the areas of academic and commercial research, agriculture, medical diagnostics and pharmaceutical development. Our work is complex and cutting-edge, and our people are curious, creative thinkers who understand that good data drives smart decisions.
Widely recognized as the industry leader in custom oligonucleotides for molecular biology applications, IDT has developed proprietary technologies for genomics applications such as next generation sequencing (NGS), CRISPR genome editing, synthetic biology, digital PCR and RNA interference. Our products are used in diagnostic tests for many forms of cancer and most inherited and infectious diseases, serving over 120,000 life sciences researchers. With the help of IDT’s probes and primers, a new lab at the International Space Station successfully conducted molecular biology experiments in the weak “microgravity” of space, an important step forward for space travel and habitation. Learn more about Integrated DNA Technologies by visiting www.idtdna.com.
Widely recognized as the industry leader in custom oligonucleotides for molecular biology applications, IDT has developed proprietary technologies for genomics applications such as next generation sequencing (NGS), CRISPR genome editing, synthetic biology, digital PCR and RNA interference. Our products are used in diagnostic tests for many forms of cancer and most inherited and infectious diseases, serving over 120,000 life sciences researchers. With the help of IDT’s probes and primers, a new lab at the International Space Station successfully conducted molecular biology experiments in the weak “microgravity” of space, an important step forward for space travel and habitation. Learn more about Integrated DNA Technologies by visiting www.idtdna.com.